Icon PublicCompany share price today

(ICLR)

Icon PublicCompany share price is $207.51 & ₹17,633.37 as on 21 Dec 2024, 2.30 'hrs' IST

$207.51

▲

2.9

(1.42%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Icon PublicCompany share price in Dollar and Rupees. Guide to invest in Icon PublicCompany from India. Also see the sentimental analysis on Indian investors investing in Icon PublicCompany. Get details on the Indian mutual funds that are investing in Icon PublicCompany. Get Analyst recommendations and forecasts along with all the Icon PublicCompany's financials.

Icon PublicCompany share price movements

Today's Low: $200.69
Today's High: $209.87
$207.51
3.29%
Downside
Day's Volatility :4.37%
Upside
1.12%
52 Weeks Low: $183.38
52 Weeks High: $347.72
$207.51
11.63%
Downside
52 Weeks Volatility :47.26%
Upside
40.32%

Icon PublicCompany Returns

Period	Icon Public Limited Company	Sector (Health Care)	Index (Russel 2000)
3 Months	-29.97%	-11.1%	0.0%
6 Months	-34.51%	-6.0%	0.0%
1 Year	-26.05%	2.7%	0.0%
3 Years	-32.5%	0.6%	-19.7%

Icon PublicCompany Key Statistics

in dollars & INR

Previous Close	$204.61
Open	$200.88
Today's High	$209.87
Today's Low	$200.69
Market Capitalization	$16.9B
Today's Volume	$786.8K
52 Week High	$347.7225
52 Week Low	$183.38
Revenue TTM	$8.3B
EBITDA	$1.7B
Earnings Per Share (EPS)	$8.98
PE Ratio	22.79
Profit Margin	9.0%
Quarterly Earnings Growth YOY	0.2%
Return On Equity TTM	7.99%

How to invest in Icon PublicCompany from India?

It is very easy for Indian residents to invest directly in Icon PublicCompany from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Icon PublicCompany stock in both Indian Rupees (INR) and US Dollars (USD). Search for Icon PublicCompany or ICLR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Icon PublicCompany or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Icon PublicCompany shares which would translate to 0.004 fractional shares of Icon PublicCompany as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Icon PublicCompany, in just a few clicks!

Returns in Icon PublicCompany for Indian investors in Rupees

Investment Value

₹1,00,000

Icon PublicCompany investment value today

Current value as on today

₹1,28,244

Returns

₹28,244

(+28.24%)

Returns from Icon PublicCompany Stock

₹26,048 (false-26.05%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Icon PublicCompany

-45%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Icon PublicCompany on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -45% less investors are searching Icon PublicCompany in the last 30 days versus the previous period.

Global Institutional Holdings in Icon PublicCompany

WCM Investment Management
8.06%
Massachusetts Financial Services Company
4.92%
T. Rowe Price Associates, Inc.
4.06%
Wellington Management Company LLP
3.73%
Ninety One UK Limited
3.27%
Lazard Asset Management LLC
2.86%

Analyst Recommendation on Icon PublicCompany

Buy

86%Buy

13%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Icon PublicCompany(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Icon PublicCompany

What analysts predicted

Upside of 32.27%

Current:

$207.51

Target:

$274.47

Insights on Icon PublicCompany

Price Movement
In the last 3 months, ICLR stock has moved down by -31.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 2.12B → 2.03B (in $), with an average decrease of 4.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 146.91M → 197.12M (in $), with an average increase of 25.5% per quarter
ICLR vs TMO (1 yr)
In the last 1 year, Icon Public Limited Company has experienced a drawdown of -26.6%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 26.1%
ICLR vs A (3 yr)
In the last 3 years, Icon Public Limited Company has experienced a drawdown of -27.6%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 8.8%
Price to Sales
ForICLR every $1 of sales, investors are willing to pay $2.1, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.7 for every $1 of sales.

Icon PublicCompany Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.6B	↑ 47.62%
Net Income	$322.8M	↑ 18.27%
Net Profit Margin	12.44%	↓ 3.08%

	FY19	Y/Y Change
Revenue	$2.8B	↑ 8.09%
Net Income	$374.0M	↑ 15.85%
Net Profit Margin	13.33%	↑ 0.89%

	FY20	Y/Y Change
Revenue	$2.8B	↓ 0.3%
Net Income	$327.8M	↓ 12.35%
Net Profit Margin	11.72%	↓ 1.61%

	FY21	Y/Y Change
Revenue	$5.5B	↑ 95.93%
Net Income	$153.2M	↓ 53.27%
Net Profit Margin	2.79%	↓ 8.93%

	FY22	Y/Y Change
Revenue	$7.7B	↑ 41.24%
Net Income	$505.3M	↑ 229.87%
Net Profit Margin	6.53%	↑ 3.74%

	FY23	Y/Y Change
Revenue	$8.1B	↑ 4.89%
Net Income	$612.3M	↑ 21.18%
Net Profit Margin	7.54%	↑ 1.01%

	Q2 FY23	Q/Q Change
Revenue	$2.1B	↑ 3.87%
Net Income	$163.7M	↑ 40.3%
Net Profit Margin	7.96%	↑ 2.06%

	Q3 FY23	Q/Q Change
Revenue	$2.1B	↑ 0.0%
Net Income	$163.7M	↑ 0.0%
Net Profit Margin	7.96%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$2.1B	↑ 1.72%
Net Income	$187.4M	↑ 14.53%
Net Profit Margin	8.97%	↑ 1.01%

	Q1 FY24	Q/Q Change
Revenue	$2.1B	↑ 1.42%
Net Income	$146.9M	↓ 21.62%
Net Profit Margin	6.93%	↓ 2.04%

	Q2 FY24	Q/Q Change
Revenue	$2.1B	↑ 0.0%
Net Income	$146.9M	↑ 0.0%
Net Profit Margin	6.93%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$2.0B	↓ 4.25%
Net Income	$197.1M	↑ 34.18%
Net Profit Margin	9.71%	↑ 2.78%

	FY18	Y/Y Change
Profit	$769.5M	↑ 5.85%

	FY19	Y/Y Change
Profit	$831.7M	↑ 8.09%

	FY20	Y/Y Change
Profit	$808.0M	↓ 2.85%

	FY21	Y/Y Change
Profit	$1.5B	↑ 86.65%

	FY22	Y/Y Change
Profit	$2.2B	↑ 46.82%

	FY23	Y/Y Change
Profit	$2.4B	↑ 8.39%

	Q2 FY23	Q/Q Change
Profit	$606.0M	↑ 3.93%

	Q3 FY23	Q/Q Change
Profit	$606.0M	↑ 0.0%

	Q4 FY23	Q/Q Change
Profit	$469.8M	↓ 22.46%

	Q1 FY24	Q/Q Change
Profit	$476.9M	↑ 1.51%

	Q2 FY24	Q/Q Change
Profit	$476.9M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$591.4M	↑ 24.01%

	FY18	Y/Y Change
Operating Cash Flow	$264.0M	↑ 441.67%
Investing Cash Flow	$-37.3M	↓ 79.03%
Financing Cash Flow	$-108.4M	↓ 9.12%

	FY19	Y/Y Change
Operating Cash Flow	$412.5M	↑ 56.26%
Investing Cash Flow	$-162.0M	↑ 334.44%
Financing Cash Flow	$-125.4M	↑ 15.69%

	FY20	Y/Y Change
Operating Cash Flow	$594.7M	↑ 44.16%
Investing Cash Flow	$-46.6M	↓ 71.25%
Financing Cash Flow	$-235.0M	↑ 87.41%

	FY21	Y/Y Change
Operating Cash Flow	$829.1M	↑ 39.42%
Investing Cash Flow	$-6.0B	↑ 12834.2%
Financing Cash Flow	$5.1B	↓ 2276.28%

	FY22	Y/Y Change
Operating Cash Flow	$563.3M	↓ 32.06%
Investing Cash Flow	$-145.9M	↓ 97.58%
Financing Cash Flow	$-864.2M	↓ 116.9%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$341.5M	↑ 94.6%
Investing Cash Flow	$-35.5M	↑ 26.59%
Financing Cash Flow	$-258.7M	↑ 64.69%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$341.5M	↑ 0.0%
Investing Cash Flow	$-35.5M	↑ 0.0%
Financing Cash Flow	$-258.7M	↑ 0.0%

Icon PublicCompany Technicals Summary

Sell

Neutral

Buy

Icon PublicCompany is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Icon PublicCompany Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Icon Public Limited Company	-2.47%	-34.51%	-26.05%	-32.5%	21.41%
Idexx Laboratories, Inc.	-1.5%	-16.12%	-25.59%	-35.59%	56.17%
Agilent Technologies Inc.	1.86%	-0.42%	-3.63%	-14.2%	57.76%
Thermo Fisher Scientific, Inc.	1.54%	-7.4%	-0.95%	-19.59%	59.75%
Danaher Corp.	-2.77%	-10.99%	-0.79%	-28.51%	49.15%
Iqvia Holdings Inc.	-0.17%	-7.86%	-14.0%	-28.72%	27.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Icon Public Limited Company	22.79	22.79	0.96	13.97	0.08	0.04	NA	118.39
Idexx Laboratories, Inc.	39.52	39.52	4.31	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.02	30.02	2.26	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.35	32.35	1.97	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	42.75	42.75	3.02	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	25.19	25.19	1.01	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Icon Public Limited Company	Buy	$16.9B	21.41%	22.79	9.0%
Idexx Laboratories, Inc.	Buy	$33.5B	56.17%	39.52	22.53%
Agilent Technologies Inc.	Buy	$38.4B	57.76%	30.02	21.75%
Thermo Fisher Scientific, Inc.	Buy	$197.6B	59.75%	32.35	14.48%
Danaher Corp.	Buy	$163.3B	49.15%	42.75	16.39%
Iqvia Holdings Inc.	Buy	$35.8B	27.38%	25.19	9.17%

About Icon PublicCompany

icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. we specialise in the strategic development, management and analysis of programmes that support clinical development - from compound selection to phase i-iv clinical studies. in a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. we have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. we are also an 'end-to-end' pharmacovigilance service provider and this includes post marketing surveillance activities too.

Organization	Icon PublicCompany
Employees	42250
CEO	Dr. Steven A. Cutler MBA, Ph.D.
Industry	Health Technology

Management People of Icon PublicCompany

Name	Title
Dr. Steven A. Cutler MBA, Ph.D.	CEO & Director
Dr. John Climax Ph.D.	Founder & Independent Non-Executive Director
Mr. Nigel Clerkin A.C.A.	Chief Financial Officer
Mr. James Miskel	President of ICON Laboratory & Early Phase Services
Dr. Gregory Licholai M.B.A., M.D.	Chief Medical & Innovation Officer
Dr. Ute Berger	President of Development & Commercialisation Solutions
Ms. Rose Kidd	President of Global Operations Delivery
Dr. Chris Smyth BSc Ph.D., MBA	President of ICON Biotech
Ms. Laurie Dohmeyer	Interim Chief Commercial Officer
Dr. Anuradha Rajput	Managing Director of ICON Central Laboratories - India

Important FAQs about investing in Icon PublicCompany from India :

What is Icon PublicCompany share price today?

Icon PublicCompany share price today stands at $207.51, Open: $200.88 ; Previous Close: $204.61 ; High: $209.87 ; Low: $200.69 ; 52 Week High: $347.72 ; 52 Week Low: $183.38. The stock opens at $200.88, after a previous close of $204.61. The stock reached a daily high of $209.87 and a low of $200.69, with a 52-week high of $347.72 and a 52-week low of $183.38.

Can Indians buy Icon PublicCompany shares?

Yes, Indians can invest in the Icon PublicCompany (ICLR) from India.

With INDmoney, you can buy Icon PublicCompany at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Icon PublicCompany at zero transaction cost.

How can I buy Icon PublicCompany shares from India?

It is very easy to buy Icon PublicCompany from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Icon PublicCompany be purchased?

Yes, you can buy fractional shares of Icon PublicCompany with INDmoney app.

What are the documents required to start investing in Icon PublicCompany stocks?

To start investing in Icon PublicCompany, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.